Graf Akcie JNJ (Johnson & Johnson). Diskuze k akciím JNJ. Aktuální informace JNJ.

Základní informace o společnosti Johnson & Johnson (Akcie JNJ)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 422B
Hodnota podniku (EV) 441.3B
Tržby 89.19B
EBITDA 30.408B
Zisk 17.767B
Růst v tržbách Q/Q 27.14 %
Růst v tržbách Y/Y 10.79 %
P/E (Cena vůči ziskům) 23.93
Forward P/E 0.01
EV/Sales 4.95
EV/EBITDA 14.51
EV/EBIT 21.66
PEG 1.67
Price/Sales 4.73
P/FCF 18.70
Price/Book 6.67
Účetní hodnota na akcii 24.19
Hotovost na akcii 9.63
FCF vůči ceně 5.35 %
Počet zaměstnanců 134,500
Tržba na zaměstnance 663.123k
Profit margin 17.82 %
Operating margin 25.23 %
Gross margin 65.58 %
EBIT margin 22.84 %
EBITDA margin 34.09 %
EPS - Zisk na akcii 6.74
EPS - Kvartální růst 48.50 %
EPS - Očekávaný růst příští rok 7.27 %
Return on assets 10.23 %
Return on equity 27.01 %
ROIC 10.04 %
ROCE 14.79 %
Dluhy/Equity 1.76
Čistý dluh/EBITDA 1.13
Current ratio 1.39
Quick Ratio 1.13
Volatilita 1.38
Beta 0.50
RSI 43.36
Cílová cena analytiků 167
Známka akcie (dle analytiků) 1.78
Insider ownership 0.08 %
Institutional ownership 69.81 %
Počet akcií 2.632B
Procento shortovaných akcií 0.62 %
Short ratio 3.14 %
Dividenda 4.14
Procentuální dividenda 2.57 %
Dividenda/Zisk 61.42 %
Obchodovaná od 1978
Země United States

Finanční výsledky akcie JNJ

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$82,584$82,059$81,581$76,450$71,890$70,074
Cost Of Goods Sold$28,427$27,556$27,091$25,439$21,789$21,536
Gross Profit$54,157$54,503$54,490$51,011$50,101$48,538
Research And Development Expenses$12,159$11,355$10,775$10,594$9,143$9,046
SG&A Expenses$22,084$22,178$22,540$21,520$20,067$21,203
Other Operating Income Or Expenses$-2,899$-2,525$-1,405$42$-210$2,064
Operating Expenses$66,087$64,731$63,582$58,777$52,087$50,878
Operating Income$16,497$17,328$17,999$17,673$19,803$19,196
Total Non-Operating Income/Expense------
Pre-Tax Income$16,497$17,328$17,999$17,673$19,803$19,196
Income Taxes$1,783$2,209$2,702$16,373$3,263$3,787
Income After Taxes$14,714$15,119$15,297$1,300$16,540$15,409
Other Income------
Income From Continuous Operations$14,714$15,119$15,297$1,300$16,540$15,409
Income From Discontinued Operations------
Net Income$14,714$15,119$15,297$1,300$16,540$15,409
EBITDA$24,040$25,012$26,544$24,634$24,651$23,622
EBIT$16,809$18,003$19,615$18,992$20,897$19,876
Basic Shares Outstanding2,6332,6452,6822,6922,7372,772
Shares Outstanding2,6712,6842,7292,7452,7892,813
Basic EPS$5.59$5.72$5.70$0.48$6.04$5.56
EPS - Earnings Per Share$5.51$5.63$5.61$0.47$5.93$5.48
# 2020 2019 2018 2017 2016 2015
Current Ratio1.20581.25891.4741.4112.47392.17
Long-term Debt / Capital0.34030.30820.31660.33770.24170.153
Debt/Equity Ratio0.55730.46570.51010.57480.38520.2791
Gross Margin65.578166.419366.792566.724769.691269.2668
Operating Margin19.97621.116522.062723.117127.546327.3939
EBIT Margin20.353821.939124.043624.842429.06828.3643
EBITDA Margin29.109830.480532.53732.222434.289933.7101
Pre-Tax Profit Margin19.97621.116522.062723.117127.546327.3939
Net Profit Margin17.81718.424618.75071.700523.007421.9896
Asset Turnover0.47220.52030.53340.4860.50910.5252
Inventory Turnover Ratio3.04233.0553.15052.90232.67552.6743
Receiveable Turnover6.08315.66675.78675.66726.1456.5282
Days Sales In Receivables60.002464.411863.075664.406159.398255.911
ROE - Return On Equity23.25325.422525.60082.1609--
Return On Tangible Equity-55.4889-69.3182-83.5354-5.205479.760864.8609
ROA - Return On Assets8.41319.585510.00110.826411.713211.55
ROI - Return On Investment15.34117.587417.49511.431217.811818.3425
Book Value Per Share24.037122.59122.443622.426626.01825.8243
Operating Cash Flow Per Share0.08940.58720.46630.9406-0.22770.4238
Free Cash Flow Per Share-0.96290.67150.82221.1161-0.93050.104

Porovnání s konkurencí: Akcie JNJ

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
JNJ 23.93 1.67 10.79 % 7.27 % 27.01 % 6.67 17.82 %
Akcie ABT 32.91 2.96 27.95 % -5.10 % 19.26 % 6.29 12.99 %
Akcie ABT 32.91 2.96 27.95 % -5.10 % 19.26 % 6.29 12.99 %
Akcie GSK 16.60 3.36 N/A % -14.00 % 29.69 % 4.85 16.86 %
Akcie GILD 16.42 0.56 20.13 % -20.85 % 27.79 % 4.69 0.50 %
Akcie GSK 16.60 3.36 N/A % -14.00 % 29.69 % 4.85 16.86 %
Akcie GILD 16.42 0.56 20.13 % -20.85 % 27.79 % 4.69 0.50 %
Akcie LLY 35.62 1.63 16.46 % 27.92 % 101.98 % 39.72 25.24 %
Akcie MRK 35.60 1.38 2.87 % 13.14 % 19.42 % 7.90 14.72 %
Akcie MDT 43.33 2.49 13.14 % 26.47 % 7.62 % 3.24 11.97 %
Akcie LLY 35.62 1.63 16.46 % 27.92 % 101.98 % 39.72 25.24 %
Akcie MRK 35.60 1.38 2.87 % 13.14 % 19.42 % 7.90 14.72 %
Akcie MDT 43.33 2.49 13.14 % 26.47 % 7.62 % 3.24 11.97 %
Akcie PFE 17.66 1.97 4.96 % 50.00 % 19.81 % 3.72 22.95 %
Akcie PFE 17.66 1.97 4.96 % 50.00 % 19.81 % 3.72 22.95 %
Akcie SYK 47.63 1.93 15.47 % 8.41 % 15.61 % 7.45 11.14 %
Akcie SYK 47.63 1.93 15.47 % 8.41 % 15.61 % 7.45 11.14 %

Nedávné obchody insiderů: Akcie JNJ

Jméno Obchod Cena Objem
Peter Fasolo
Exec VP and Chief HR Officer
Option
12 Feb 2021
$166.58 $2,144,384
Ashley Mc Evoy
EVP, WW Chair, and Medical Devices
Option
12 Feb 2021
$166.58 $2,188,195
Michael E Sneed
EVP, Global Corp Aff, and CCO
Option
12 Feb 2021
$166.58 $1,534,368
Paulus Stoffels
Vice Chair and Exec Committee
Option
12 Feb 2021
$166.58 $5,840,628
Jennifer L Taubert
EVP, WW Chair, and Pharmaceuticals
Option
12 Feb 2021
$166.58 $2,266,487
Michael H Ullmann
Exec VP and General Counsel
Option
12 Feb 2021
$166.58 $2,406,082
Kathryn E Wengel
EVP and Chief GSC Officer
Option
12 Feb 2021
$166.58 $1,726,102
Joseph J Wolk
Exec VP and CFO
Option
12 Feb 2021
$166.58 $847,226
Robert J Decker
Controller and CAO
Option
12 Feb 2021
$166.58 $218,220
Alex Gorsky
Chairman and CEO
Option
12 Feb 2021
$166.58 $12,510,991
Thibaut Mongon
Exec VP, WW Chair, and Consumer
Option
12 Feb 2021
$166.58 $1,190,214

Diskuze k akciím JNJ